Schedule 13G ownership disclosure
PHIO PHARMACEUTICALS CORP
Common Stock, par value $0.0001 per share · CUSIP: 71880W501
Event date: 2025-11-03
- Filing-level shares
- 800,000.00
- Percent of class
- 9.8%
- Orca Capital AG
Shares: 800,000.00 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-021091
- Form type
- SCHEDULE 13G/A
- Filer
- Orca Capital AG
- CIK
- CIK 2052389
- Filed
- Nov 06, 2025
- Reporting period
- Nov 03, 2025
- Description
- Schedule 13G beneficial ownership